Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A phase I trial of sns-314, a novel and selective pan-aurora kinase inhibitor, in advanced solid tumor patients Robert, F., Verschraegen, C., Hurwitz, H., Uronis, H., Advani, R., Chen, A., Taverna, P., Wollman, M., Fox, J., Michelson, G. AMER SOC CLINICAL ONCOLOGY. 2009
View details for Web of Science ID 000276606602302